Inventor · disambiguated record
Lorne R. Palmer
Also filed as: PALMER LORNE · PALMER LORNE R · PALMER LORNE RALPH
28 granted patents·29 pending applications·3,693 citations·filing 2000–2024
98Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC23ARBUTUS BIOPHARMA CORP19MACLACHLAN IAN3UNIV BRITISH COLUMBIA3GENEVANT SCIENCES GMBH2
Top patents by PatentIndex Score
57 records- 0199US7799565B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Sep 21, 2010·367 cites·26 claims
- 0299US7745651B2Cationic lipids and methods of usePROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Jun 29, 2010·368 cites·4 claims
- 0398US11718852B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 8, 2023·5 cites·32 claims
- 0498US11141378B2Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Oct 12, 2021·42 cites·30 claims
- 0598US9518272B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·116 cites·22 claims
- 0698US9504651B2Lipid compositions for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·144 cites·14 claims
- 0798US9492386B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Nov 15, 2016·72 cites·20 claims
- 0898US9404127B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·131 cites·22 claims
- 0998US9364435B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·194 cites·20 claims
- 1098US9018187B2Cationic lipids and methods for the delivery of therapeutic agentsPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·116 cites·33 claims
- 1198US8822668B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Sep 2, 2014·99 cites·23 claims
- 1298US8492359B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2011·Granted Jul 23, 2013·109 cites·21 claims
- 1398US8058069B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2009·Granted Nov 15, 2011·585 cites·22 claims
- 1498US7901708B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2003·Granted Mar 8, 2011·344 cites·22 claims
- 1597US12129467B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 29, 2024·2 cites·24 claims
- 1697US11318098B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted May 3, 2022·3 cites·30 claims
- 1797US11298320B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Apr 12, 2022·3 cites·30 claims
- 1897US9006417B2Non-liposomal systems for nucleic acid deliveryYAWORSKI ED·Filed 2011·Granted Apr 14, 2015·55 cites·24 claims
- 1997US8569256B2Cationic lipids and methods for the delivery of therapeutic agentsHEYES JAMES·Filed 2010·Granted Oct 29, 2013·485 cites·20 claims
- 2097US7807815B2Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·68 cites·28 claims
- 2196US8329070B2Liposomal apparatus and manufacturing methodMACLACHLAN IAN·Filed 2010·Granted Dec 11, 2012·158 cites·13 claims
- 2296US6852334B1Cationic peg-lipids and methods of useUNIV BRITISH COLUMBIA·Filed 2000·Granted Feb 8, 2005·90 cites·43 claims
- 2395US11191849B2Compositions and methods for delivering messenger RNAARBUTUS BIOPHARMA CORP·Filed 2017·Granted Dec 7, 2021·10 cites·10 claims
- 2495US8598333B2SiRNA silencing of genes expressed in cancerMACLACHLAN IAN·Filed 2007·Granted Dec 3, 2013·27 cites·8 claims
- 2594US9926560B2Lipid encapsulating interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Mar 27, 2018·6 cites·14 claims
- 2694US7189705B2Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizersUNIV BRITISH COLUMBIA·Filed 2001·Granted Mar 13, 2007·93 cites·62 claims
- 2791US2025034571A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2889US2024035030A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 2988US2023372245A1Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 3080US9181545B2Lipid encapsulating interfering RNAMACLACHLAN IAN·Filed 2010·Granted Nov 10, 2015·1 cites·7 claims
- 3180US2023165973A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 3279US2020268664A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 3378US2021267891A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 3478US2020113832A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 3577US2021220274A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 3674US2019167586A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 3773US2020297870A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 3872US2019032051A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 3969US2017258719A1Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4068US2018092848A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4167US2025215042A1Mannose-targeted compositionsGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 4267US2019071669A1Lipid encapsulating interfering rnaARBUTUS PIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 4367US2017260523A1Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4467US2018085312A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4566US2022160899A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4663US2016151284A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4763US2017042814A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4861US2004241855A1Cationic peg-lipids and methods of useUNIV BRITISH COLUMBIA·Filed 2004·Application pending·0 cites
- 4957US2014161894A1Sirna silencing of genes expressed in cancerALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 5057US2016256567A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lorne R. Palmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →